U.S. flag

An official website of the United States government

NM_000101.4(CYBA):c.203+5G>A AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jan 11, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003987638.1

Allele description [Variation Report for NM_000101.4(CYBA):c.203+5G>A]

NM_000101.4(CYBA):c.203+5G>A

Gene:
CYBA:cytochrome b-245 alpha chain [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16q24.2
Genomic location:
Preferred name:
NM_000101.4(CYBA):c.203+5G>A
HGVS:
  • NC_000016.10:g.88647096C>T
  • NG_007291.1:g.8954G>A
  • NM_000101.4:c.203+5G>AMANE SELECT
  • LRG_52:g.8954G>A
  • NC_000016.9:g.88713504C>T
  • NM_000101.3:c.203+5G>A
Links:
dbSNP: rs200590340
NCBI 1000 Genomes Browser:
rs200590340
Molecular consequence:
  • NM_000101.4:c.203+5G>A - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004804387Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Jan 11, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

NAPDH Oxidase-Specific Flow Cytometry Allows for Rapid Genetic Triage and Classification of Novel Variants in Chronic Granulomatous Disease.

Sacco KA, Smith MJ, Bahna SL, Buchbinder D, Burkhardt J, Cooper MA, Hartog NL, Kobrynski L, Patel KP, Abraham RS.

J Clin Immunol. 2020 Jan;40(1):191-202. doi: 10.1007/s10875-019-00712-6. Epub 2019 Dec 8.

PubMed [citation]
PMID:
31813112

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV004804387.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Variant summary: CYBA c.203+5G>A alters a conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. Several computational tools predict a significant impact on normal splicing: One predict the variant abolishes a 5' splicing donor site. Three predict the variant weakens a 5' donor site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00024 in 244146 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in CYBA causing Chronic Granulomatous Disease (0.00024 vs 0.00061), allowing no conclusion about variant significance. c.203+5G>A has been reported in the literature in one individual affected with Chronic Granulomatous Disease (Sacco_2019). The report does not provide unequivocal conclusions about association of the variant with Chronic Granulomatous Disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 31813112). ClinVar contains an entry for this variant (Variation ID: 534660). Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024